AbCellera Biologics (ABCL) Change in Taxes (2021 - 2025)
AbCellera Biologics' Change in Taxes history spans 5 years, with the latest figure at -$10.1 million for Q4 2025.
- For the quarter ending Q4 2025, Change in Taxes fell 165.44% year-over-year to -$10.1 million, compared with a TTM value of -$29.8 million through Dec 2025, down 548.7%, and an annual FY2025 reading of -$29.8 million, down 548.7% over the prior year.
- Change in Taxes for Q4 2025 was -$10.1 million at AbCellera Biologics, up from -$12.2 million in the prior quarter.
- The five-year high for Change in Taxes was $70.0 million in Q1 2022, with the low at -$87.2 million in Q3 2022.
- Average Change in Taxes over 5 years is -$4.7 million, with a median of -$3.2 million recorded in 2024.
- Biggest YoY gain for Change in Taxes was 1242.66% in 2022; the steepest drop was 11467.01% in 2022.
- Tracing ABCL's Change in Taxes over 5 years: stood at $16.0 million in 2021, then plummeted by 434.78% to -$53.7 million in 2022, then skyrocketed by 103.31% to $1.8 million in 2023, then surged by 763.41% to $15.4 million in 2024, then plummeted by 165.44% to -$10.1 million in 2025.
- Per Business Quant, the three most recent readings for ABCL's Change in Taxes are -$10.1 million (Q4 2025), -$12.2 million (Q3 2025), and -$3.2 million (Q2 2025).